Patents by Inventor Baogen Su

Baogen Su has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10308674
    Abstract: The present invention discloses a process for preparing L-arabinose from Gum Arabic comprising the steps of catalytical hydrolysis of L-arabinose from gum arabic followed by the purification steps including neutralization using alkali, adsorption bleaching, electrodialysis desalination, adsorption separation of impurities and crystallization, with the absolute purity of L-arabinose up to 98% and the recovery as high as 25%˜29% of material weight. The disclosed process has such advantages as low cost, environmental-friendliness and simple operation, showing promising in industrial production.
    Type: Grant
    Filed: May 7, 2015
    Date of Patent: June 4, 2019
    Assignee: ZHEJIANG UNIVERSITY
    Inventors: Zongbi Bao, Minhui Huang, Zhiguo Zhang, Qiwei Yang, Baogen Su, Huabin Xing, Qilong Ren, Yiwen Yang
  • Patent number: 10301341
    Abstract: The present invention discloses a process for preparing high-purity raffinose from defatted wheat germ comprising the steps of percolate extraction of raffinose from defatted wheat germ, decoloration by extraction from the abstraction liquid, electrodialysis desalination, impurity removal by simulated moving bed, concentration and crystallization, with the absolute purity of raffinose as high as 98% and the recovery up to 75%. The process is not only reliable and easy to operate, but also easy to realize industrial production and control the parameters.
    Type: Grant
    Filed: May 7, 2015
    Date of Patent: May 28, 2019
    Assignee: ZHEJIANG UNIVERSITY
    Inventors: Zongbi Bao, Minhui Huang, Shuran Duan, Qianqian Zhou, Zhiguo Zhang, Qiwei Yang, Baogen Su, Huabin Xing, Qilong Ren, Yiwen Yang
  • Publication number: 20180051047
    Abstract: The present invention discloses a process for preparing high-purity raffinose from defatted wheat germ comprising the steps of percolate extraction of raffinose from defatted wheat germ, decoloration by extraction from the abstraction liquid, electrodialysis desalination, impurity removal by simulated moving bed, concentration and crystallization, with the absolute purity of raffinose as high as 98% and the recovery up to 75%. The process is not only reliable and easy to operate, but also easy to realize industrial production and control the parameters.
    Type: Application
    Filed: May 7, 2015
    Publication date: February 22, 2018
    Inventors: ZONGBI BAO, MINHUI HUANG, SHURAN DUAN, QIANQIAN ZHOU, ZHIGUO ZHANG, QIWEI YANG, BAOGEN SU, HUABIN XING, QILONG REN, YIWEN YANG
  • Publication number: 20180030077
    Abstract: The present invention discloses a process for preparing L-arabinose from Gum Arabic comprising the steps of catalytical hydrolysis of L-arabinose from gum arabic followed by the purification steps including neutralization using alkali, adsorption bleaching, electrodialysis desalination, adsorption separation of impurities and crystallization, with the absolute purity of L-arabinose up to 98% and the recovery as high as 25%˜29% of material weight. The disclosed process has such advantages as low cost, environmental-friendliness and simple operation, showing promising in industrial production.
    Type: Application
    Filed: May 7, 2015
    Publication date: February 1, 2018
    Applicant: ZHEJIANG UNIVERSITY
    Inventors: ZONGBI BAO, MINHUI HUANG, ZHIGUO ZHANG, QIWEI YANG, BAOGEN SU, HUABIN XING, QILONG REN, YIWEN YANG
  • Patent number: 6444681
    Abstract: A method for treating conditions or diseases associated with deleterious vasoconstriction of the small arteries and arterioles of one or more organs or parts of a patient's body. In one embodiment, the method comprises administering a therapeutically effective amount of an antagonist to the &agr;2C-adrenergic receptor (&agr;2C-AR) to a patient with Raynaud's Phenomenon. Such method is used to ameliorate the cold-induced or stress-induced vasoreactive response that is associated with Raynaud's Phenomenon. The &agr;2C-AR antagonist is administered to the subject either prior to or after exposure of the patient to the cold or to stressIn another embodiment, the method is used to reduce the extent of deleterious vasoconstriction that occurs in the small arteries, arterioles, and microcirculation of the lungs, heart, kidneys, skin, or gastrointestinal tract of a patient, particularly a scleroderma patient.
    Type: Grant
    Filed: June 9, 2000
    Date of Patent: September 3, 2002
    Assignee: The Ohio State University Research Foundation
    Inventors: Nicholas Flavahan, Sheila Flavahan, Maqsood Chotani, Srabani Mitra, Baogen Su